Skip to main content
OpenTrials

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

295 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Completed

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

NCT06122649

Conditions
Plaque Psoriasis
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
View all 21 locations
View Trial Details
Completed

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

NCT06108544

Conditions
Plaque Psoriasis
Locations
  • Total Dermatology Birmingham, Alabama, United States
  • Cahaba Dermatology Skin Health Center Hoover, Alabama, United States
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Noble Clinical Research Tucson, Arizona, United States
View all 217 locations
View Trial Details
Completed

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

NCT06088043

Conditions
Plaque Psoriasis
Locations
  • Saguaro Dermatology Associates, LLC - Probity - PPDS Phoenix, Arizona, United States
  • First OC Dermatology - Fountain Valley Fountain Valley, California, United States
  • Center for Dermatology Clinical Research Fremont, California, United States
  • UCLA University of California Los Angeles Los Angeles, California, United States
View all 132 locations
View Trial Details
Completed

A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

NCT05811234

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • DE12 Ahaus, Germany
  • DE07 Augsburg, Germany
  • DE06 Cologne, Germany
  • DE08 Freising, Germany
View all 37 locations
View Trial Details
Completed

A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

NCT06602219

Conditions
Plaque Psoriasis
Locations
  • Cahaba Dermatology Skin Health Center Birmingham, Alabama, United States
  • Dermatology Trial Associates Bryant, Arkansas, United States
  • Zenith Research, Inc. Beverly Hills, California, United States
  • First OC Dermatology Research Inc Fountain Valley, California, United States
View all 58 locations
View Trial Details
Completed

A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

NCT05855967

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +12 more
Locations
  • King George Hospital Vizag, Andhra Pradesh, India
  • All India Institute of Medical Sciences Raipur, Chhattisgarh, India
  • V.S. General Hospital Ahmedabad, Gujarat, India
  • Amber Clinic Ahmedabad, Gujarat, India
View all 14 locations
View Trial Details

Related conditions